Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 2/20 | 0.63 |
| ▸ | CCR7 | P32248 | 1/20 | 0.63 |
| ▸ | CXCR2 | P25025 | 19/20 | 0.50 |
| ▸ | CXCR1 | P25024 | 17/20 | 0.46 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31114666 | 0.94 | CCR6 (0.62) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114674 | 0.90 | CCR6 (0.74) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114776 | 0.90 | CCR6 (0.77) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114646 | 0.89 | CCR6 (0.56) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114829 | 0.89 | CCR6 (0.56) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114831 | 0.88 | CCR6 (0.60) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114700 | 0.88 | CCR6 (0.62) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114739 | 0.88 | CCR6 (0.48) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114810 | 0.87 | CCR6 (0.61) | CCR6CCR7CXCR2CXCR1CXCR3 | |
| SCHEMBL31114711 | 0.86 | CXCR2 (0.57) | CCR6CCR7CXCR2CXCR1CXCR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703354-A1 | COMPOUND AS CCR6 ANTAGONIST, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | Wuhan Createrna Science and Technology Co.,Ltd. (CN) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024222865-A1 | COMPOUND AS CCR6 ANTAGONIST, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 武汉朗来科技发展有限公司 | 2024-10-31 | — | — | WO | disclosed |